Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), HCA Healthcare (HCA)

Tipranks - Wed Jan 28, 5:52PM CST

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elicio Therapeutics (ELTXResearch Report) and HCA Healthcare (HCAResearch Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

Elicio Therapeutics (ELTX)

JonesTrading analyst Soumit Roy maintained a Buy rating on Elicio Therapeutics today and set a price target of $18.00. The company’s shares closed last Tuesday at $8.45.

According to TipRanks.com, Roy has 0 stars on 0-5 stars ranking scale with an average return of -12.9% and a 27.5% success rate. Roy covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Acrivon Therapeutics, Inc., and Bicara Therapeutics Inc. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Elicio Therapeutics with a $15.50 average price target.

See Insiders’ Hot Stocks on TipRanks >>

HCA Healthcare (HCA)

In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on HCA Healthcare, with a price target of $529.00. The company’s shares closed last Tuesday at $505.84.

According to TipRanks.com, Langston is ranked 0 out of 5 stars with an average return of -7.3% and a 41.1% success rate. Langston covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Privia Health Group, and P3 Health Partners. ;'>

HCA Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $497.18, representing a -1.5% downside. In a report released today, TipRanks – Google also upgraded the stock to Buy with a $541.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.